You searched for "litigation"

2165 results found

SCOPE Independent Prescriber Bursary 2024 Awards

SCOPE celebrates excellence in optometry with the 2024 Independent Prescriber Bursary Awards.

Excel tips

In previous articles Microsoft Outlook and OneNote have been the focus. Here, it is Microsoft Excel that gains the spotlight. Excel is a powerful tool, likely known, at least to a basic degree, to all readers. Below are walkthroughs of...

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...

Atlas Of Orbital Imaging

It was an absolute pleasure to review this beautifully written textbook. Authorship is from a diverse, international group of experienced and respected oculoplastic surgeons with an interest in orbital disease. A significant contribution to most of these chapters has been...

Episcleral brachytherapy (EB) for retinoblastoma (RB)

This retrospective study consisted of 11 eyes treated either with Iodine (I) -125 or Ruthenium (R) -106EB with a mean apical dose of 44Gy. There were five in group B (46%), three in group C (27%) and three in group...

Impact of solar eclipses on vision

Solar retinopathy occurs as a result of mechanical and photochemical damage to the retina caused by exposure to excessive light. The authors presented the optical coherence tomography (OCT) and OCT-angiography findings of five patients who looked at the solar eclipse...

IN FOCUS - Beyond 2020: what next for global eye health?

The year 2020 is a pivotal year for global eye health. It marks the conclusion of ‘VISION 2020: The Right to Sight’ which has guided action for the past two decades, and the end of the World Health Organization (WHO)...

2030 In Sight: Ending avoidable sight loss

Over 2.2 billion people on our planet live with visual impairment or blindness with 1.1 billion unable to access affordable treatment. The 2030 In Sight sector strategy led by the International Agency for the Prevention of Blindness (IAPB) is an...

Paediatric uveitis in India

This article was a retrospective review of paediatric patients presenting to a tertiary hospital in India. Records over a three year period were reviewed. The authors highlight that children account for about 2.2-13.8% of uveitis patients and are at greater...

Intravitreal dexamethasone implant for diabetic macular oedema

The authors report on the three-year outcomes of the Ozurdex Dexamethasone (DEX) intravitreal implant multi-centre trial for the treatment of diabetic macular oedema (DME). Patients with DME (best-corrected vision of 20/50 to 20/200 and central retinal thickness of ≥300µm) were...

Retinal blood flow changes in glaucoma

This study examined the changes in retinal blood flow and vessel diameter after IOP reduction in high- and low-pressure glaucoma; exfoliation glaucoma (ExG) and normal-tension glaucoma (NTG). Glaucoma progression is seen at times in eyes despite IOP reduction and changes...

Relationship between nocturnal intraocular pressure elevation and diurnal intraocular pressure level in NTG patients

This group studies Korean normo-tension glaucoma (NTG) patients over a 24-hour period to assess if there was a relationship between nocturnal intraocular pressure (IOP) and diurnal IOP. They have previously suggested differences in diurnal IOP may have varying mechanisms of...